The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Indirect comparisons of triplet therapy as compared to novel hormonal therapy doublets in patients with metastatic castration sensitive prostate cancer.
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Zaryab Bin Riaz
No Relationships to Disclose
 
Anum Riaz
No Relationships to Disclose
 
Mahnoor Islam
No Relationships to Disclose
 
Rabbia Siddiqi
No Relationships to Disclose
 
Waleed Ikram
No Relationships to Disclose
 
Muhammad Daim Bin Zafar
No Relationships to Disclose
 
Parminder Singh
Consulting or Advisory Role - EMD Serono; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
 
Irbaz Bin Riaz
No Relationships to Disclose
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Castle Biosciences; Horizon CME; Myovant Sciences; Myovant Sciences; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)